Search bioRxiv⌕ Search

Biology subjects

Sarusi, Y.

Publications and source records attributed to Sarusi, Y..

2 recordsLinked to original sources

Inducible formation of fusion transcripts upregulates haploinsufficient CHD2 gene expression

Modes of action of long noncoding RNAs (lncRNAs) are poorly understood. CHASERR is a broadly expressed lncRNA located immediately upstream of the promoter of the CHD2 gene. We show that antisense oligonucleotides (ASOs) targeting conserved motifs in CHASERRs last exon induce the formation of a fusion transcript joining CHASERR to CHD2. This fusion transcript is exported to the cytoplasm and translated into full-length CHD2 protein. Deleting the same motifs in mice mimics the ASO effect, increasing CHD2 protein without causing the deleterious effects associated with full CHASERR ablation. The fusion transcripts are also expressed endogenously, induced in activated neurons, and their constitutive induction affects neuronal gene expression and chromatin accessibility. Perinatal introduction of the ASO into Chd2+/- mice up-regulates CHD2 expression and alleviates behavioral phenotypes caused by CHD2 haploinsufficiency, providing a therapeutic route to CHD2 haploinsufficiency. This concept of targeting upstream genes with ASOs to induce transcript fusion can be extended to other gene pairs, and is thus a broadly relevant approach for increasing haploinsufficient gene expression.

molecular biology↗

Alterations in background ECoG activity and behavioral deficits in a mouse model of CHD2-related developmental delay

Heterozygous loss of function mutations in the CHD2 gene, encoding for chromodomain helicase DNA-binding protein 2, are associated with severe childhood-onset epilepsy, global developmental delay, and autistic features. Here, we characterized the behavioral and epileptic phenotypes of a mouse model harboring a frameshift truncating mutation in the Chd2 gene (Chd2WT/m and Chd2m/m mice). Genetic background dramatically affected the phenotypes. While no phenotypes were observed on the pure C57BL/6J background, crossing these mice onto the 129X1/SvJ genetic background gradually uncovered neurodevelopmental phenotypes. Transcriptomic analysis identified Kcnj11 as a potential genetic modifier. On the 129X1/SvJ background, Chd2m/m mice demonstrated growth retardation, and both Chd2WT/m and Chd2m/m showed motor deficits, including clasping behavior and reduced abilities to balance on a rotating rod. Autistic-like features were also observed, with Chd2m/m showing reduced nest-building abilities and Chd2WT/m demonstrating increased repetitive-like behavior in the marble burying test and altered social behavior. Quantitative analysis of electrocorticographic (ECoG) recordings revealed neuronal changes consisting of a global reduction in the total power of background activity in Chd2WT/m and Chd2m/m mice, as well as increased susceptibility to seizures induced by acute administration of 4-aminopyridine. Overall, this mouse model recapitulates multiple key phenotypes observed in CHD2 patients, providing a valuable platform to study the molecular basis and treatment options for this intractable disease.

neuroscience↗